In-utero stem cell transplantation: clinical use and therapeutic potential

Marco De Santis, Carmen De Luca, Ilenia Mappa, Elena Cesari, T Quattrocchi, Terryann Spagnuolo, Daniela Visconti, Giuseppe Noia, Alessandro Caruso

Risultato della ricerca: Contributo in rivistaArticolo in rivista

11 Citazioni (Scopus)


[Fr:]Early evidence suggests that in-utero stem cell transplantation represents a new therapeutic strategy for different congenital disease. Moreover, gene therapy constitutes one of the most promising new approach to treat a wide spectrum of genetic disorders. It was shown that the fetus could represent an ideal recipient because of his immunologic early naiveté in gestation that reduces the risk of immunoreactions. Clinical experience in human fetus was performed in order to treat immunodeficiency and metabolic disorders, hemoglobinopathies and some other genetic diseases. Use of alternative source (i.e., cord blood, placenta, membrane, amniotic fluid, fetal tissue) of stem cell transplanted has been only one of the several strategies to improve donor cell advantages on host stem cell. The present review focused on the clinical use and therapeutic potential of in-utero stem cell transplantation, reporting the outcome of human cases treated and the limits of this therapy and possible future applications.
Lingua originaleEnglish
pagine (da-a)387-398
Numero di pagine12
RivistaMinerva Ginecologica
Stato di pubblicazionePubblicato - 2011


  • Adult Stem Cells
  • Embryonic Stem Cells
  • Female
  • Fetal Diseases
  • Fetus
  • Gene Therapy
  • Hematopoietic Stem Cell Transplantation
  • Humans
  • Mesenchymal Stem Cell Transplantation
  • Pregnancy
  • Stem Cell Transplantation


Entra nei temi di ricerca di 'In-utero stem cell transplantation: clinical use and therapeutic potential'. Insieme formano una fingerprint unica.

Cita questo